Study

Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. – Cost Effective Supplements

Evaluation of chemoprevention of oral cancer with Spirulina fusiformis.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/8584455


Conclusion of this study

Within one year of discontinuing supplements, 9 of 20 (45%) complete responders with SF developed recurrent lesions. Supplementation with SF did not result in increased serum concentration of retinol or beta-carotene, nor was it associated with toxicity. This is the first human study evaluating the chemopreventive potential of SF. More studies in different settings and different populations are needed for further evaluation.


Supplements analyzed in this study

Spirulina

Health conditions analyzed in this study

Oral Cancer


Moderately Positive
Spirulina


Functions related to this study

Digestion


Moderately Positive
Spirulina


Body systems related to this study


Digestive System
Scroll to top